为皮肤提供精油的纳米乳液:系统性审查
Thais Leticia Moreira da Silva1, Anna Claudia Morais de Oliveira Capote1, Flávio Luís Beltrame2
1Pharmaceutical Science Post-Graduation Program, State University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.
Phytotherapy research : PTR
|January 10, 2026
概括
纳米乳液增强了局部使用的精油 (EO),改善了皮肤的益处,如抗炎和抗菌作用. 由于高偏差和研究变异,需要进一步研究.
科学领域:
- 制药科学 制药科学
- 皮肤病学 皮肤病学
- 纳米技术 纳米技术
背景情况:
- 精油 (EOs) 具有众多的健康益处,但由于挥发性,不稳定性和水溶性差,在局部应用方面面临挑战.
- 纳米乳液为克服这些局限性提供了一个有希望的解决方案,提高了EO的输送和有效性.
研究的目的:
- 系统地审查纳米乳液的有效性,安全性和局限性,作为局部精油管理的输送系统.
- 评估纳米乳液对精油生物活性和皮肤相互作用的影响.
主要方法:
- 在PubMed,Scopus和Web of Science数据库中进行了系统的文献搜索,遵循PRISMA 2020指南.
- 包括专注于局部EO纳米乳液的研究在体内动物或人体模型中用于伤口愈合,抗炎/止痛作用,化品应用和透皮输送.
- 被排除的研究仅限于体外/体外测定,孤立的EO成分或非局部应用.
主要成果:
- 审查了22篇涉及18种植物物种的文章,证明纳米乳液显著改善了EO生物活性,包括抗炎,抗氧化和抗菌作用.
- 纳米乳液增强了皮肤的透性,生物可用性和皮肤屏障功能,同时减少皮肤刺激,并使受控释放.
- 尽管有所改善,但在各个研究中都发现了高偏差风险和显著的异质性,限制了直接比较.
结论:
- 纳米乳液显示出在各种皮肤学和治疗应用中增强局部精油输送和疗效的潜力.
- 进一步进行高质量的临床前和临床试验至关重要,以验证这些发现,并确定精油纳米乳液的安全性和有效性.
- 解决研究异质性和偏见对于基于纳米乳液的精油配方可靠评估至关重要.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Drug Delivery Systems: Different Types
406
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
406
Transdermal Drug Delivery Systems
233
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
233
Ophthalmic Drug Delivery Systems
283
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
283


